Premarket Mover: Jaguar Health Inc (JAGX) Up 4.35%

Jaguar Health Inc (JAGX) is higher by Monday morning, with the stock adding 4.35% in pre-market trading to 1.44. JAGX's short-term technical score of 34 indicates that the stock has traded less bullishly over the last month than 66% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 64% of stocks. Jaguar Health Inc has fallen 35.21% over the past month, closing at $2.13 on November 1. During this period of time, the stock fell as low as $1.37 and as high as $2.25. JAGX has an average analyst recommendation of Strong Buy. The company has an average price target of $5.88.

JAGX has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on JAGX!

See Full JAGX Report

Jaguar Health Inc has a Long-Term Technical rank of 48. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 52% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, JAGX ranks better than 70% of stocks.

Important Dates for Investors in JAGX:

-Jaguar Health Inc is set to release earnings on 2/15/2022. During their last earnings release the company posted EPS of $-0.78. -We do not have a set dividend date for Jaguar Health Inc at this time. Click Here To Get The Full Report on Jaguar Health Inc (JAGX)